{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:34:15Z","timestamp":1774924455526,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,21]],"date-time":"2015-03-21T00:00:00Z","timestamp":1426896000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0891-2","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T06:36:05Z","timestamp":1426833365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis"],"prefix":"10.1186","volume":"15","author":[{"given":"Corine E","family":"Delsing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina L","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal P","family":"Bleeker-Rovers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank L","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai G","family":"Netea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,21]]},"reference":[{"issue":"2","key":"891_CR1","first-page":"108","volume":"10","author":"JR Chandler","year":"1989","unstructured":"Chandler JR. Malignant external otitis and osteomyelitis of the base of the skull. Am J Otol. 1989;10(2):108\u201310.","journal-title":"Am J Otol"},{"issue":"12","key":"891_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00405-006-0118-7","volume":"263","author":"D Stodulski","year":"2006","unstructured":"Stodulski D, Kowalska B, Stankiewicz C. Otogenic skull base osteomyelitis caused by invasive fungal infection. Case report and literature review. Eur Arch Otorhinolaryngol. 2006;263(12):1070\u20136.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"891_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0002-9343(88)90592-X","volume":"85","author":"J Rubin","year":"1988","unstructured":"Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. 1988;85(3):391\u20138.","journal-title":"Am J Med"},{"issue":"2","key":"891_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1469-0691.2010.03231.x","volume":"17","author":"CC Blyth","year":"2011","unstructured":"Blyth CC, Gomes L, Sorrell TC, da Cruz M, Sud A, Chen SC. Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect. 2011;17(2):306\u201311.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"891_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","volume":"47","author":"BH Segal","year":"2008","unstructured":"Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47(5):674\u201383.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"891_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1086\/376456","volume":"188","author":"MG Netea","year":"2003","unstructured":"Netea MG, Warris A, Van der Meer JW, Fenton MJ, Verver-Janssen TJ, Jacobs LE, et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis. 2003;188(2):320\u20136.","journal-title":"J Infect Dis"},{"issue":"6","key":"891_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/1469-0691.12389","volume":"20","author":"E Gabrielli","year":"2014","unstructured":"Gabrielli E, Fothergill AW, Brescini L, Sutton DA, Marchionni E, Orsetti E, et al. Osteomyelitis caused by Aspergillus species: a review of 310 reported cases. Clin Microbiol Infect. 2014;20(6):559\u201365.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"891_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/myc.12165","volume":"57","author":"P Koehler","year":"2014","unstructured":"Koehler P, Tacke D, Cornely OA. Aspergillosis of bones and joints - a review from 2002 until today. Mycoses. 2014;57(6):323\u201335.","journal-title":"Mycoses"},{"issue":"2","key":"891_CR9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","volume":"12","author":"JP Latge","year":"1999","unstructured":"Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12(2):310\u201350.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"891_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.idc.2007.07.003","volume":"21","author":"S Gupta","year":"2007","unstructured":"Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. 2007;21(3):617\u201338. vii.","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"891_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.diagmicrobio.2008.12.005","volume":"63","author":"D Horn","year":"2009","unstructured":"Horn D, Sae-Tia S, Neofytos D. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry. Diagn Microbiol Infect Dis. 2009;63(4):384\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"891_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1439-0507.1999.tb00010.x","volume":"42","author":"I Vennewald","year":"1999","unstructured":"Vennewald I, Henker M, Klemm E, Seebacher C. Fungal colonization of the paranasal sinuses. Mycoses. 1999;42 Suppl 2:33\u20136.","journal-title":"Mycoses"},{"key":"891_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1749-6632.2012.06759.x","volume":"1273","author":"MS Gresnigt","year":"2012","unstructured":"Gresnigt MS, Netea MG, van de Veerdonk FL. Pattern recognition receptors and their role in invasive aspergillosis. Ann N Y Acad Sci. 2012;1273:60\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"891_CR14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/iai.65.2.564-570.1997","volume":"65","author":"E Cenci","year":"1997","unstructured":"Cenci E, Perito S, Enssle KH, Mosci P, Latge JP, Romani L, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun. 1997;65(2):564\u201370.","journal-title":"Infect Immun"},{"issue":"1","key":"891_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54\u201361.","journal-title":"N Engl J Med"},{"issue":"11","key":"891_CR16","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.4049\/jimmunol.1202601","volume":"190","author":"MS Gresnigt","year":"2013","unstructured":"Gresnigt MS, Becker KL, Smeekens SP, Jacobs CW, Joosten LA, van der Meer JW, et al. Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3. J Immunol. 2013;190(11):5629\u201339.","journal-title":"J Immunol"},{"issue":"10","key":"891_CR17","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203(10):2271\u20139.","journal-title":"J Exp Med"},{"issue":"12","key":"891_CR18","first-page":"3573","volume":"119","author":"S Eyerich","year":"2009","unstructured":"Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009;119(12):3573\u201385.","journal-title":"J Clin Invest"},{"issue":"6","key":"891_CR19","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","volume":"174","author":"K Boniface","year":"2005","unstructured":"Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005;174(6):3695\u2013702.","journal-title":"J Immunol"},{"key":"891_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1471-2334-14-166","volume":"14","author":"CE Delsing","year":"2014","unstructured":"Delsing CE, Gresnigt MS, Leentjens J, Preijers F, Frager FA, Kox M, et al. Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis. 2014;14:166.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"891_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.20091844","volume":"207","author":"IL King","year":"2010","unstructured":"King IL, Kroenke MA, Segal BM. GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J Exp Med. 2010;207(5):953\u201361.","journal-title":"J Exp Med"},{"issue":"1","key":"891_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri1996","volume":"7","author":"K Shortman","year":"2007","unstructured":"Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7(1):19\u201330.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"891_CR23","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/eji.201141540","volume":"41","author":"Y Zhan","year":"2011","unstructured":"Zhan Y, Carrington EM, van Nieuwenhuijze A, Bedoui S, Seah S, Xu Y, et al. GM-CSF increases cross-presentation and CD103 expression by mouse CD8(+) spleen dendritic cells. Eur J Immunol. 2011;41(9):2585\u201395.","journal-title":"Eur J Immunol"},{"issue":"Suppl 2","key":"891_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.12-S2-22","volume":"12","author":"EK Waller","year":"2007","unstructured":"Waller EK. The role of sargramostim (rhGM-CSF) as immunotherapy. Oncologist. 2007;12 Suppl 2:22\u20136.","journal-title":"Oncologist"},{"issue":"1","key":"891_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1517\/14728214.11.1.23","volume":"11","author":"K Meier","year":"2006","unstructured":"Meier K, Nanney LB. Emerging new drugs for wound repair. Expert Opin Emerg Drugs. 2006;11(1):23\u201337.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"891_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bph.12196","volume":"169","author":"H Muhl","year":"2013","unstructured":"Muhl H, Scheiermann P, Bachmann M, Hardle L, Heinrichs A, Pfeilschifter J. IL-22 in tissue-protective therapy. Br J Pharmacol. 2013;169(4):761\u201371.","journal-title":"Br J Pharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0891-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0891-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T23:06:46Z","timestamp":1717801606000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0891-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,21]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0891-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,21]]},"assertion":[{"value":"25 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"140"}}